Thus, significant elevation in serum PTH concentration as a major marker for SHPT is predicted in patients with CKD that a PTH level higher than >300 pg/mL can be detected in about one-fourth of CKD patients (8,9) that can be accompanied with cardiac and skeletal diseases in long-term period. Here, PTH is linked to bone disorder.